Insider · CIK 0001242116

FINCK BARBARA K

Reports to the SEC for 3 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001242116

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-27	FBRXForte Biosciences, Inc. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−18.4K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)]D Disposition to Issuer	Director	DDisposition to Issuer	−166 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,000 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,000 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31K sh	—	—	0
2025-03-19	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2024-08-20	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-03-21	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+175K sh	—	—	175,000
2023-09-19	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-01-04	Comera Life Sciences Holdings, Inc.A Award	Director	AAward	+6,756 sh	$1.23	+$8,309.88	23,033
2023-01-04	Comera Life Sciences Holdings, Inc.Warrant (Right to Buy)P Purchase	Director	PPurchase	+6,756 sh	$0.25	+$1,689	6,756
2023-01-04	Comera Life Sciences Holdings, Inc.P Purchase	Director	PPurchase	+6,756 sh	$1.23	+$8,309.88	23,033
2023-01-04	Comera Life Sciences Holdings, Inc.Warrants (right to buy)A Award	Director	AAward	+6,756 sh	$0.25	+$1,689	6,756
2022-06-01	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-05-19	Comera Life Sciences Holdings, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+37.1K sh	—	—	37,111
2022-03-16	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,166 sh	—	—	4,166
2022-03-16	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2018-09-10	CHRSCoherus Oncology, Inc.S Sale	Chief Medical Officer	SSale	−1,760 sh	$18.58	−$32.7K	37,043
2018-09-10	CHRSCoherus Oncology, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,760 sh	—	—	82,941
2018-09-10	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,760 sh	$1.42	+$2,499.2	38,803
2018-08-13	CHRSCoherus Oncology, Inc.S Sale	Chief Medical Officer	SSale	−1,760 sh	$19.02	−$33.5K	37,043
2018-08-13	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,760 sh	$1.42	+$2,499.2	38,803
2018-08-13	CHRSCoherus Oncology, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,760 sh	—	—	84,701
2018-07-10	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,260 sh	$1.42	+$1,789.2	38,303
2018-07-10	CHRSCoherus Oncology, Inc.S Sale	Chief Medical Officer	SSale	−1,260 sh	$15.00	−$18.9K	37,043
2018-07-10	CHRSCoherus Oncology, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,260 sh	—	—	86,461
2018-07-09	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+500 sh	$1.42	+$710	37,543
2018-07-09	CHRSCoherus Oncology, Inc.S Sale	Chief Medical Officer	SSale	−500 sh	$15.03	−$7,515	37,043
2018-07-09	CHRSCoherus Oncology, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−500 sh	—	—	87,721
2018-06-18	CHRSCoherus Oncology, Inc.S Sale	Chief Medical Officer	SSale	−1,760 sh	$15.00	−$26.4K	37,043
2018-06-18	CHRSCoherus Oncology, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,760 sh	—	—	88,221
2018-06-18	CHRSCoherus Oncology, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+1,760 sh	$1.42	+$2,499.2	38,803
2018-02-01	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+130K sh	—	—	130,000
2017-12-15	CHRSCoherus Oncology, Inc.A Award	Chief Medical Officer	AAward	+7,545 sh	—	—	34,336
2017-08-06	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+67K sh	—	—	67,000
2016-05-11	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+78.5K sh	—	—	78,472
2015-04-01	CHRSCoherus Oncology, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2014-11-12	CHRSCoherus Oncology, Inc. · Series C Preferred StockC Conversion	Chief Medical Officer	CConversion	−5,286 sh	—	—	0
2014-11-12	CHRSCoherus Oncology, Inc.C Conversion	Chief Medical Officer	CConversion	+21.5K sh	—	—	21,505
2014-11-12	CHRSCoherus Oncology, Inc.C Conversion	Chief Medical Officer	CConversion	+5,286 sh	—	—	26,791
2014-11-12	CHRSCoherus Oncology, Inc. · Series B Preferred StockC Conversion	Chief Medical Officer	CConversion	−21.5K sh	—	—	0

Recent filings

Accepted (ET)
Aug 274
FINCK BARBARA K0001242116-26-000001
SEC(opens sec.gov)
Mar 214
FINCK BARBARA K0001415889-25-008776
SEC(opens sec.gov)
Aug 224
FINCK BARBARA K0001415889-24-022001
SEC(opens sec.gov)
Mar 254
FINCK BARBARA K0001415889-24-009032
SEC(opens sec.gov)
Sep 204
FINCK BARBARA K0001209191-23-050192
SEC(opens sec.gov)
Feb 144/A
FINCK BARBARA K0001062993-23-003497
SEC(opens sec.gov)
Feb 145
FINCK BARBARA K0001062993-23-003515
SEC(opens sec.gov)
Jan 64
FINCK BARBARA K0001062993-23-000611
SEC(opens sec.gov)
Jun 24
FINCK BARBARA K0001209191-22-033620
SEC(opens sec.gov)
May 164/A
FINCK BARBARA K0001209191-22-029187
SEC(opens sec.gov)
Mar 184
FINCK BARBARA K0001209191-22-020074
SEC(opens sec.gov)
Sep 124
FINCK BARBARA K0000899243-18-024270
SEC(opens sec.gov)

Companies

Address

C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BUILDING 6

DALLAS, TX, 75247